Cargando…

Trial of Amiloride in Type 2 Diabetes With Proteinuria

INTRODUCTION: Renal sodium (Na(+)) retention and extracellular fluid volume expansion are hallmarks of nephrotic syndrome, which occurs even in the absence of activation of hormones that stimulate renal Na(+) transporters. Plasmin-dependent activation of the epithelial Na(+) channel has been propose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unruh, Mark L., Pankratz, V. Shane, Demko, John E., Ray, Evan C., Hughey, Rebecca P., Kleyman, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584552/ https://www.ncbi.nlm.nih.gov/pubmed/28890943 http://dx.doi.org/10.1016/j.ekir.2017.05.008

Ejemplares similares

Urinary Plasmin(ogen) as a Prognostic Factor for Hypertension
por: Ray, Evan C., et al.
Publicado: (2018)

Effects of amiloride on acetylcholine‐dependent arterial vasodilation evolve over time in mice on a high salt diet
por: Mutchler, Stephanie M., et al.
Publicado: (2022)

In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
por: Trimarchi, H., et al.
Publicado: (2017)

Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs
por: Vu, Kiem, et al.
Publicado: (2023)

Amiloride: A review
por: Sun, Qianhui, et al.
Publicado: (2020)

The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study
por: Li, Ruizhao, et al.
Publicado: (2021)

Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000)

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
por: Brown, Morris J, et al.
Publicado: (2016)

Cesium-associated hypokalemia successfully treated with amiloride
por: Horn, Sarah, et al.
Publicado: (2015)

Stability of extemporaneously compounded amiloride nasal spray
por: Yellepeddi, Venkata, et al.
Publicado: (2020)

Amiloride hydrochloride methanol disolvate
por: Ton, Cuong Quoc, et al.
Publicado: (2010)

Pharmacokinetics of intranasal amiloride in healthy volunteers
por: Yellepeddi, Venkata K., et al.
Publicado: (2023)

Successful Management of Refractory Type 1 Renal Tubular Acidosis with Amiloride
por: Oguejiofor, Patrick, et al.
Publicado: (2017)

Amiloride-sensitive channels in type I fungiform taste cells in mouse
por: Vandenbeuch, Aurelie, et al.
Publicado: (2008)

Correlation of enhanced thrombospondin-1 expression, TGF-β signalling and proteinuria in human type-2 diabetic nephropathy
por: Hohenstein, Bernd, et al.
Publicado: (2008)

A Pilot Trial on the Effect of Levothyroxine on Proteinuria in Patients With Advanced CKD
por: Blackaller, Guillermo Navarro, et al.
Publicado: (2020)

Amiloride-Sensitive Sodium Channels and Pulmonary Edema
por: Althaus, Mike, et al.
Publicado: (2011)

Saline Infusion and Amiloride in the Management of Lithium Toxicity
por: Czerniewski, Ian W D, et al.
Publicado: (1990)

Bortezomib for Reduction of Proteinuria in IgA Nephropathy
por: Hartono, Choli, et al.
Publicado: (2018)

Vascular Access Site for Renal Replacement Therapy in Acute Kidney Injury: A Post hoc Analysis of the ATN Study
por: Ng, Yue-Harn, et al.
Publicado: (2017)

Amiloride derivatives enhance insulin release in pancreatic islets from diabetic mice
por: Gunawardana, Subhadra C, et al.
Publicado: (2005)

Monitoring for proteinuria in patients with type 2 diabetes mellitus
por: Liang, Huifang, et al.
Publicado: (2015)

Lithium-induced polyuria and amiloride: Key issues and considerations
por: Pattanayak, Raman Deep, et al.
Publicado: (2017)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

ENaC blockade in proteinuria‐associated extracellular fluid volume overload – effective but risky
por: Ray, Evan C.
Publicado: (2018)

Advanced Diabetic Nephropathy with Nephrotic Range Proteinuria: A Pilot Study of the Long-Term Efficacy of Subcutaneous ACTH Gel on Proteinuria, Progression of CKD, and Urinary Levels of VEGF and MCP-1
por: Tumlin, J. A., et al.
Publicado: (2013)

An unusual presentation of atrial myxoma with haematuria and proteinuria
por: Bushnell, James R., et al.
Publicado: (2011)

Low-Level Proteinuria in Systemic Lupus Erythematosus
por: Chedid, Alice, et al.
Publicado: (2020)

A Patient Presenting with AKI, Proteinuria, and Anasarca
por: Rosenstiel, Paul, et al.
Publicado: (2023)

Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial
por: Fuchs, Sandra Costa, et al.
Publicado: (2016)

Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial
por: McKee, Justin B, et al.
Publicado: (2015)

Failed Neuroprotection of Combined Inhibition of L-Type and ASIC1a Calcium Channels with Nimodipine and Amiloride
por: Ort, Jonas, et al.
Publicado: (2020)

Effect of vitamin D on proteinuria in type 2 diabetic patients
por: Momeni, Ali, et al.
Publicado: (2017)

Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial
por: Lucca, Marcelo B., et al.
Publicado: (2023)

Implications of Complete Proteinuria Remission at any Time in Focal Segmental Glomerulosclerosis: Sparsentan DUET Trial
por: Trachtman, Howard, et al.
Publicado: (2023)

Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis
por: Gipson, Debbie S., et al.
Publicado: (2020)

Proteinuria and glomerular injury associated with the anti-angiogenesis drug Vargatef™
por: Manjunath, Veena, et al.
Publicado: (2011)

Low serum sodium levels at hospital admission: Outcomes among 2.3 million hospitalized patients
por: Al Mawed, Saleem, et al.
Publicado: (2018)

Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease
por: Trimarchi, H., et al.
Publicado: (2016)

Effect of Amiloride to Retinal Toxicity Induced by Tissue Plasminogen Activator
por: Kim, Ungsoo Samuel, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_udfaghlolkd87u5i6nbbe4r91g